New Delhi: Coronavirus is wreaking havoc in the world. Every country is trying to make a vaccine of this virus as soon as possible. For this, many big researchers are trialing about its medicine. The name of Oxford University is also included in this list. At the University of Oxford, he prepared a drug of corona under the name AZD1222 whose trial is still underway.
Rain wreaks havoc in Jammu amid Corona crisis, Birma bridge damaged
The initial trial of this vaccine is currently underway. In which it has been successful. After positive results, this drug is being tried at another level. Talking about this trial, Pascal Soriot, CEO of pharmaceutical company AstraZeneca, said that like every country, we also want to eliminate this virus for which this drug is being made. He said that even after all the trials, if the vaccine does not work then all the hard work will go in vain. Therefore, the company will not make money from this vaccine until the WHO announces the end of the epidemic.
Only such food can make defense against Corona
Pascal Soriot said that we have already contracted this medicine from India. He said that we have signed an agreement to produce 1 billion vaccines from the Serum Institute of India. Which aims to make about 1 billion doses of vaccine by 2021. AstraZeneca company will supply 400 million vaccines to the US, 100 million vaccines to Britain. But this is possible only when the vaccine being made at Oxford University will prove to be effective.
